Aaron M. Moss

Pharmacokinetics in drug discovery.

M. Bermejo, V. Casabó, A. Ruiz-Garcia, 2008, Journal of pharmaceutical sciences.

The Role of the Equilibrative Nucleoside Transporter 1 (ENT1) in Transport and Metabolism of Ribavirin by Human and Wild-Type or Ent1(-/-) Mouse Erythrocytes

C. Endres, J. Unadkat, D. Choi, 2009, Journal of Pharmacology and Experimental Therapeutics.

The role of the equilibrative nucleoside transporter 1 on tissue and fetal distribution of ribavirin in the mouse

C. Endres, J. Unadkat, Rajgopal Govindarajan, 2016, Biopharmaceutics & drug disposition.

Role of the equilibrative and concentrative nucleoside transporters in the intestinal absorption of the nucleoside drug, ribavirin, in wild-type and Ent1(-/-) mice.

C. Endres, J. Unadkat, D. Choi, 2012, Molecular pharmaceutics.

Target‐Mediated Drug Disposition Pharmacokinetic/Pharmacodynamic Model‐Informed Dose Selection for the First‐in‐Human Study of AVB‐S6‐500

A. Giaccia, R. Tabibiazar, G. McIntyre, 2019, Clinical and translational science.

A phase I, first-in-human study of TAK-164, an antibody–drug conjugate, in patients with advanced gastrointestinal cancers expressing guanylyl cyclase C

D. Ryan, A. Parikh, B. Bahamon, 2023, Cancer Chemotherapy and Pharmacology.

The Role of Nucleoside Transporters in the Erythrocyte Disposition and Oral Absorption of Ribavirin in the Wild-Type and Equilibrative Nucleoside Transporter 1(−/−) Mice

C. Endres, J. Unadkat, D. Choi, 2009, Journal of Pharmacology and Experimental Therapeutics.